Clinical trials for advancing innovative interventions for neurodegenerative diseases
Ente erogante: Commissione Europea - Horizon Europe
Scadenza
13 aprile 2027
361 giorni rimanenti
Forma
Non specificata
Budget totale
Non specificato
Contributo max
Non specificato
Descrizione del bando
Expected Outcome:This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes:The scientific and clinical communities make effective use of state-of-the-art knowledge, data, technologies, tools, methods, best practices, and trainings to underpin and complement the development of innovative interventions aimed at more effective treatments for neurodegenerative diseases.The scientific and clinical communities benefit from the exchange of data, knowledge and best practices, thereby strengthening their collaboration in the EU, the Associated Countries and beyond.The scientific and clinical communities make wide use of relevant databases and/or integrate them with existing infrastructures for storage and sharing of collected data according to FAIR[1] principles, thereby encouraging further use of the data.Policymakers, funders, scientific and clinical communities, patient organisations, regulators, and other relevant bodies are informed of the research advances made and the requirements for a widespread implementation of the innovative therapeutic interventions and complementary approaches.Patients and caregivers are constructively engaged with the research, ensuring that their needs are catered for, with the aim of tangibly benefitting from the interventions. Scope:Neurodegenerative diseases are a high burden for patients, caregivers, health systems and society. Given the limitations with current therapeutic solutions, including that they primarily address symptoms rather than underlying causes and can have serious side effects, together with the increasing prevalence of neurodegenerative diseases in an aging population, there is a huge need to develop more innovative, safer and more effective the
Non capisci questo bando?
L'AI di Bandiora te lo spiega in modo semplice: requisiti, importi, scadenze e a chi è rivolto, tutto chiaro.
Registrati e fatti spiegare il bando dall'AIArea geografica
Tematiche
Requisiti dettagliati
Questo bando è rivolto a - tipologie di impresa in 3 settori ATECO nell'area eu.
Scopri con l'AI se questo bando è adatto alla tua azienda
Analisi automatica di compatibilità, requisiti e matching in tempo reale
Prova gratis 7 giorniQuesto bando fa per la tua azienda?
L'AI di Bandiora analizza la compatibilità con la tua azienda in tempo reale e ti assiste nella compilazione della candidatura, passo dopo passo.
Altri bandi che potrebbero interessarti
Support to test EIC innovations for public and private procurers
Commissione Europea
Scadenza: 17 aprile 2026
Accelerating the discovery and development of chemicals and innovative advanced materials through digitalisation and artificial intelligence (IA) (Innovative Advanced Materials for the EU partnership)
Commissione Europea - Horizon Europe
Scadenza: 21 aprile 2026
Improving availability of secondary raw materials through recycling (IA)
Commissione Europea - Horizon Europe
Scadenza: 21 aprile 2026
Monitoring of secondary raw materials (CSA)
Commissione Europea - Horizon Europe
Scadenza: 21 aprile 2026